Effect of growth hormone therapy in burn patients on conservative treatment

Burns

Volumn 24, Issue 8, 1998, Pages 733-738

  Singh, K P ^a   Prasad, R ^a   Chari, P S ^a   Dash, R J ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Conservative management of burns; Insulin like growth factor 1; Protein catabolism; Recombinant human growth hormone therapy

Indexed keywords

CALCIUM; HEMOGLOBIN; HUMAN GROWTH HORMONE; IMMUNOGLOBULIN F(AB) FRAGMENT; NITROGEN; PHOSPHORUS; SERUM ALBUMIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD LEVEL; BURN; CATABOLISM; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVELOPING COUNTRY; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HEMOGLOBIN DETERMINATION; HORMONAL THERAPY; HOSPITALIZATION; HUMAN; HYPERCALCEMIA; HYPERGLYCEMIA; MALE; PROTEINURIA; SEPSIS; SUBCUTANEOUS DRUG ADMINISTRATION; WEIGHT REDUCTION; WOUND HEALING;

ADOLESCENT; ADULT; ALBUMINURIA; BURNS; CALCIUM; CHILD; CHILD, PRESCHOOL; FEMALE; GLOMERULAR FILTRATION RATE; HEMOGLOBINS; HOSPITALIZATION; HUMAN GROWTH HORMONE; HUMANS; HYPERCALCEMIA; HYPERGLYCEMIA; INSULIN-LIKE GROWTH FACTOR I; LENGTH OF STAY; MALE; NITROGEN; PHOSPHORUS; PROTEINS; RECOMBINANT PROTEINS; SEPSIS; SERUM ALBUMIN; SKIN; SURVIVAL RATE; WEIGHT LOSS; WOUND HEALING;

EID: 0032442248     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0305-4179(98)00113-2     Document Type: Article

References (39)

1. Wolfe R.R. Nutrition and metabolism in burns. Critical Care. 7:1986;19-23.
2. Batstone G.F., Levick P.I., Spurr E., Shakespeare P.G., George S.L., Ward C.M. Changes in acute phase reactants and disturbances in metabolism after burn injury. Burn. 9:1982;234.
3. Dahn M.S., Mitchell R.A., Smith S., et al. Altered immunological function and nitrogen metabolism associated with depression of plasma growth hormone. JPEN. 8:1984;690-694.
4. Nguyen T.T., Gilpin D.A., Meyer N.A., Herndon D.N. Current treatment of severely burned patients. Ann Surg. 223:1996;14-25.
5. Jenkins R.C., Ross R.J.M. Growth hormone therapy for protein catabolism. Q J Med. 89:1996;813-819.
6. Wilmore D.W., Orcutt T.W., Mason A.D. Jr, Pruitt B.A. Alterations in hypothalamic function following thermal injury. J Trauma. 15:1975;697-703.
7. Jeffries M., Vance M. Growth hormone and cortisol secretion in patients with burn injury. J Burn Care Rehab. 13:1992;391-395.
8. Jeevanandam M., Ramias L., Shamos R., Schiller W. Decreased growth hormone levels in the catabolic phase of severe injury. Surgery. 111:1992;495-502.
9. Herndon D.N., Barrow R.E., Kunkel K.R., Broemeling L., Rutan R.L. Effects of recombinant human growth hormone on donor-site healing in severely burned children. Ann Surg. 212:1990;424-431.
10. Knox J., Demling R., Wilmore D., Sarraf P., Santos A. Increased survival after major thermal injury: the effect of growth hormone therapy in adults. J Trauma. 39:1995;526-532.
11. Jayaraman V., Ramakrishnan M.K., Davies M.R. Burns in Madras, India: an analysis of 1368 patients in 1 year. Burns. 19:1993;339-344.
12. Knaus W.A., Draper E.A., Wagner D.P., Zimmerman Z.E. APACHE-II: a severity of disease classification system. Crit Care Med. 13:1985;818-819.
13. Herrin T.J. Management of pediatric patients with burns. In: Ichikawa L., editors. Pediatric Textbook of Fluids and Electrolytes. Williams & Wilkins, Baltimore, 1990. p. 388-401.
14. Elebute E.A., Stoner H.B. The grading of sepsis. Br J Surg. 70:1983;29-31.
15. Lamber K. Photometric determination of nitrogen. Wet incineration followed by formation of indophenol blue with salicylate/hypochlorite. Acta Clin Chim. 67:1976;107-110.
16. Dash R.J., England B.G., Midgley A.R. Jr, Niswender G.D. A specific nonchromatographic radioimmunoassay for human plasma cortisol. Steroids. 26:1975;647-652.
17. Prasad R., Kinsella J.L., Sacktor B. Renal adaptation to metabolic acidosis in senescent rats. Am J Physiol. 1988, 255, pp. F1183-F1190.
18. Yared A. Regulation of renal blood flow and glomerular filtration rate. In: Ichikawa L., editors. Pediatric Textbook of Fluids and Electrolytes. Williams & Wilkins, Baltimore, 1990. p. 39-53.
19. Bistrian B.R. A simple technique to estimate severity of stress. Surg Gynecol Obstet. 148:1979;675-678.
20. Voreman H.J., Schijndel R.J., Greeneveld A.B., et al. Effects of Recombinant Human Growth Hormone in Patients with Severe Sepsis. Ann Surg. 216:1992;648-655.
21. Belcher H.J.C.R., Mecer D., Judkins K.C., Shalaby S., Wise S., Marks V., Tanner N.S.B. Biosynthetic human growth hormone in burned patients: a pilot study. Burns. 15:1989;99-107.
22. Kimbrough T.D., Shernan S., Ziegler T.R., Scheltinga M., Wilmore D.W. Insulin-like growth factor-I response is comparable following intravenous and subcutaneous administration of growth hormone. J Surg Res. 51:1991;472-476.
23. Tenhave S.M., Lely A.J., Lamberts S.W. Increase in haemoglobin concentrations in growth hormone deficient adults during human recombinant growth hormone replacement therapy. Clin Endocrinol. 47:1997;565-570.
24. Jorgenson P.H., Andreassen T.T., Jorgensen K.D. Growth hormone influences collagen deposition and mechanical strength of intact rate skin: a dose response study. Acta Endocrinol. 120:1989;767-772.
25. Meyer N.A., Barrow R.E., Herndon D.N. Combined insulin-like growth factor-1 and growth hormone improves weight loss and wound healing in burned rats. J Trauma. 41:1996;1008-1112.
26. Gilpin D.A., Barrow R.E., Rutan R.L., Broemeling L., Herndon D.N. Recombinant human growth hormone accelerates wound healing in children with large cutaneous burns. Ann Surg. 220:1994;19-24.
27. Bjerknes R., Bindenes H., Laerum O.P. Altered neutrophil functions in patients with large burns. Blood Cells. 17:1990;402-405.
28. Strock L.L., Singh H., Abdullah A., Miller J., Herndon D.N. The effect of insulin-like growth factor 1 on postburn hypermetabolism. Surgery. 108:1990;161-164.
29. Ziegler T.R., Leader I. Adjunctive human growth hormone therapy in nutrition support: potential to limit septic complications in intensive care unit patients. Semin Resp Infect. 9:1994;240-247.
30. Dahn M.S., Lange M.P., Jacobs L.A. Insulin like growth factor-1 production is inhibited in human sepsis. Arch Surg. 123:1988;1409-1414.
31. Wang H.L. Prethrombotic state in burn patients. Chung Hua Cheng Hsing-Shao-Shang Wai-Ko-Tsa-Chih. 479:1993;441-446.
32. Bubber P., Singh K.P., Arora S., Bansal D.D. Effect of growth hormone on fibrinolytic system in rat. Ind J Exptl Biol. 36:1998;514-516.
33. Knox J.B., Demling R.H., Wilmore D.W., Sarraf P., Santos A.A. Hypercalcemia associated with the use of human growth hormone in an adult surgical intensive care unit. Arch Surg. 130:1995;442-445.
34. Gertner J.M., Tamborlane W.V., Hintz R.L., Horst R.L., Genel M. The effects on mineral metabolism on overnight growth hormone infusion in growth hormone deficiency. J Clin Endocrinol & Metabol. 53:1981;818-822.
35. Singh K.P., Dash R.J. Vitamin D Endocrine system. J Assoc Phys Ind. 45:1997;559-568.
36. Chipman J.J., Zerwekh J., Nicar M., Marks J., Pak C.Y.C. Effect of growth hormone administration: reciprocal changes in serum 1,25-dihydroxyvitamin D and intestinal calcium absorption. J Clin Endocrinol & Metabol. 51:1980;321-324.
37. Zaloga G.P., Chernow B. The multifactorial basis for hypocalcemia during sepsis. Ann Intern Med. 107:1987;36-41.
38. Caidhal K., Eden S., Bengtsson B.Å. Cardiovascular and renal effects of growth hormone. Clin Endocrinol. 40:1994;393-400.
39. Huang K.F., Chung D.H., Herndon D.N. Insulin-like growth factor-1 (IGF-1) reduces gut atrophy and bacterial translocation after severe burn injury. Arch Surg. 128:1993;47-53.